| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 09/14/2011 | CN101528745B Nicotinic acetylcholine receptorsub-type selective amides of diazabicycloalkanes |
| 09/14/2011 | CN101496833B Liquid external preparation for preparing total alkaloids in nux vomica |
| 09/14/2011 | CN101463085B Gene engineering monoclonal antibody combined with A-beta oligomer specificity |
| 09/14/2011 | CN101411845B Cancer-suppressing analgesic medicament |
| 09/14/2011 | CN101269096B Chinese medicine valid target for treating apoplexy disease |
| 09/14/2011 | CN101263848B Soboring-up liver-protecting tea |
| 09/14/2011 | CN101210012B Novel isoflavone nicotinic acid ester derivatives, preparing method and use thereof |
| 09/14/2011 | CN101195003B Proprietary Chinese medicine for treating apoplexy and sequela |
| 09/13/2011 | US8017785 Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine |
| 09/13/2011 | US8017726 Anti-inflammatory compounds and uses thereof |
| 09/13/2011 | US8017643 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 09/13/2011 | US8017628 Pharmaceutically active sulfonyl hydrazide derivatives |
| 09/13/2011 | US8017627 Fentanyl composition for nasal administration |
| 09/13/2011 | US8017615 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 09/13/2011 | US8017392 Hox11+, CD45− cells and methods of organ regeneration using the same |
| 09/13/2011 | US8017125 Copolymers for suppression of autoimmune diseases, and methods of use |
| 09/13/2011 | US8017115 Therapeutical use of anti-myelin associated glycoprotein (MAG) antibodies |
| 09/13/2011 | CA2691149C Process for the preparation of racemic citalopram and/or s- or r-citalopram by separation of a mixture of r-and s-citalopram |
| 09/13/2011 | CA2640451C Medicine for transnasal administration |
| 09/13/2011 | CA2539489C Methods and kits for enhancing ability to learn in a puppy or kitten |
| 09/13/2011 | CA2515590C Pten inhibitor or maxi-k channels opener |
| 09/13/2011 | CA2492410C Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 09/13/2011 | CA2486869C Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| 09/13/2011 | CA2469075C Pyrrolidine derivatives as prostaglandin modulators |
| 09/13/2011 | CA2441565C Bisarylamines as potassium channel openers |
| 09/13/2011 | CA2440238C Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 09/13/2011 | CA2356836C Novel streptococcus antigens |
| 09/13/2011 | CA2350519C Chromone enteric release formulation |
| 09/13/2011 | CA2199289C Novel compositions containing phosphoglycero ethers, and use thereof for treating neurodegenerative diseases |
| 09/12/2011 | CA2733692A1 Selegiline-containing adhesive preparation |
| 09/09/2011 | WO2011109470A1 Heteroaryl nitrile compounds useful as inhibitors of cathepsin-s |
| 09/09/2011 | WO2011109355A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | WO2011109324A1 Tetrazole compounds which selectively modulate the cb2 receptor |
| 09/09/2011 | WO2011109298A2 Therapeutic dll4 binding proteins |
| 09/09/2011 | WO2011108955A1 Multi -targeting system comprising a nanocarrier, nucleic acid(s) and non-nucleic acid based drug(s) |
| 09/09/2011 | WO2011108778A1 Composite herbal preparation composition for dementia treatment and inhibition |
| 09/09/2011 | WO2011107948A2 Ligands of insulin degrading enzyme and their uses |
| 09/09/2011 | WO2011107710A1 Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
| 09/09/2011 | WO2011107653A2 Method for treating parkinson's disease |
| 09/09/2011 | WO2011107648A1 Dendrimers as non-viral vehicles for gene therapy |
| 09/09/2011 | WO2011107647A1 Dendrimers as non-viral vehicles for gene therapy |
| 09/09/2011 | WO2011107617A1 Liquid ibuprofen/codeine pharmaceutical composition for oral administration, the method for preparation thereof and use thereof |
| 09/09/2011 | WO2011107583A1 Substituted 4-phenyl-n-alkyl-piperidines for preventing onset or slowing progression of neurodegenerative disorders |
| 09/09/2011 | WO2011107582A1 Novel pharmaceutical composition for the treatment of neurodegenerative or neurovascular diseases |
| 09/09/2011 | WO2011107480A1 Antigen binding proteins specific for serum amyloid p component |
| 09/09/2011 | WO2011107394A1 Treatment of anxiety disorders |
| 09/09/2011 | WO2011107100A1 Methods and compositions for regulation of herv4 |
| 09/09/2011 | WO2011106885A1 Oligomer-specific amyloid beta epitope and antibodies |
| 09/09/2011 | WO2011057204A9 Lrrk2-mediated neuronal toxicity |
| 09/09/2011 | WO2011050095A3 Prevention and treatment of post-operative cognitive dysfunction (pocd) |
| 09/09/2011 | WO2011041542A3 Herbal pain killer compositions |
| 09/09/2011 | WO2010123960A3 Arylsulfonamide ccr3 antagonists |
| 09/09/2011 | WO2010123956A3 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 09/09/2011 | WO2010093904A9 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf |
| 09/09/2011 | CA2811091A1 A method for inhibiting alternative pathway mediated disorders with anti-properdin antibodies that inhibit c5 interactions with properdin |
| 09/09/2011 | CA2791672A1 Positive allosteric modulators of mglur2 |
| 09/09/2011 | CA2791651A1 Compounds for immunoproteasome inhibition |
| 09/09/2011 | CA2791631A1 Therapeutic dll4 binding proteins |
| 09/09/2011 | CA2791538A1 Oligomer-specific amyloid beta epitope and antibodies |
| 09/09/2011 | CA2791457A1 Compounds, compositions, formulations and their uses in the treatment of diseases related to copper retention or hepatic disorders |
| 09/09/2011 | CA2791009A1 Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
| 09/09/2011 | CA2790654A1 Novel pharmaceutical composition for the treatment of neurodegenerative or neurovascular diseases |
| 09/09/2011 | CA2790060A1 Compounds useful for treating neurodegenerative disorders |
| 09/09/2011 | CA2789557A1 Antigen binding proteins specific for serum amyloid p component |
| 09/09/2011 | CA2789475A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 09/09/2011 | CA2789474A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 09/09/2011 | CA2789471A1 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 09/09/2011 | CA2784819A1 Method of treating parkinson's disease |
| 09/08/2011 | US20110218343 Small molecule inhibitors of rotamase enzyme activity |
| 09/08/2011 | US20110218253 Imaging-based identification of a neurological disease or a neurological disorder |
| 09/08/2011 | US20110218249 Use of hypericum perforatum extracts in the treatment of neuropathic pain |
| 09/08/2011 | US20110218246 Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
| 09/08/2011 | US20110218242 Polyunsaturated Fatty Acids for Treatment of Dementia and Pre-Dementia-Related Conditions |
| 09/08/2011 | US20110218228 Crystalline sodium atorvastatin |
| 09/08/2011 | US20110218225 Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof |
| 09/08/2011 | US20110218222 Neurorestoration with r(+) pramipexole |
| 09/08/2011 | US20110218221 Novel histone deacetylase inhibitors, process for preparation and uses thereof |
| 09/08/2011 | US20110218218 Formulations Of Indanylamines And The Use Thereof As Local Anesthetics And As Medication For Chronic Pain |
| 09/08/2011 | US20110218217 Piperidylpropionamide derivatives useful for the treatment of cns disorders including depression and panic disorder |
| 09/08/2011 | US20110218216 Extended release pharmaceutical composition of donepezil |
| 09/08/2011 | US20110218215 Compositions and Methods for Treating Social Anxiety |
| 09/08/2011 | US20110218214 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme |
| 09/08/2011 | US20110218208 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 09/08/2011 | US20110218205 Piperazine derivatives |
| 09/08/2011 | US20110218200 Methods of treating amyloid disease using analogs of 1-(4-nitrophenyl) piperazine |
| 09/08/2011 | US20110218194 Heterocyclic aspartyl protease inhibitors |
| 09/08/2011 | US20110218193 Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same |
| 09/08/2011 | US20110218192 Inhibitors Of Beta-Secretase |
| 09/08/2011 | US20110218186 Spirocyclic heterocyclic derivatives and methods of their use |
| 09/08/2011 | US20110218180 Esters of Capsaicin for Treating Pain |
| 09/08/2011 | US20110217392 Composition for countering the effects of alcohol consumption |
| 09/08/2011 | US20110217383 Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol |
| 09/08/2011 | US20110217382 Methods and Compositions for Treating Pain Comprising a Statin |
| 09/08/2011 | US20110217373 Extended release pharmaceutical compositions of guanfacine hydrochloride |
| 09/08/2011 | US20110217372 Fast dissolving oral tablets and method for production thereof |
| 09/08/2011 | US20110217371 Controlled-release microparticles and method of preparing same |
| 09/08/2011 | US20110217335 Synthesis of resorcylic acid lactones useful as therapeutic agents |
| 09/08/2011 | US20110217324 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 09/08/2011 | US20110217320 Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/08/2011 | US20110217306 C-terminal exon 5.4 of runx1/aml1 |